NIH awards $3.96 million to develop combination therapies for superbugs

Gram-negative bacteria pose a serious threat to global health because they can resist multiple antibiotics, making infections difficult to treat, according to the National Institutes of Health.

Cambridge announced as ‘investor catalyst’ hub for ARPA-H

Cambridge has been chosen as one of three national hubs for a new federal health research agency that plans to spend billions to accelerate breakthroughs

September 26, 2023

Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment | Psychedelic Invest

Vancouver, Canada, Sept. 06, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on

September 12, 2024

Atrial fibrillation diagnosis associated with 45% increased risk of mild cognitive impairment

Atrial fibrillation (AF) diagnosis was associated with a 45% increased risk of mild cognitive impairment (MCI) among a cohort of 4.3 million individuals in the

October 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.